COVID-19 vaccines could arrive in March

Under the arrangement known as COVAX, which involves 180 countries collectively securing doses from manufacturers, Botswana is due to have 940, 800 vaccines under a two-dose regimen, meaning about 20% of the population will be covered.

An update from the COVAX facility this week states that Botswana is due to receive 117, 600 doses of the AstraZeneca/SK Bio vaccine within the first quarter of the year, with other doses to follow in the second quarter of the year. The AstraZeneca/SK Bio vaccine is manufactured in South Korea under licence from AstraZeneca, the pharmaceutical giant that was amongst the first to produce a COVID-19 vaccine last year.